Furosemide and cerebrospinal fluid ions during acute respiratory acidosis.
The purpose of this study was to investigate the effects of furosemide, an inhibitor of NaCl cotransport, on cisternal cerebrospinal fluid (CSF) acid-base balance during acute respiratory acidosis (ARA). We measured blood and CSF acid-base variables in two groups (n = 7 in each) of anesthetized, paralyzed, and mechanically ventilated dogs with bilateral ligation of renal pedicles (to eliminate saluresis). After base-line samples were obtained (-1 h), furosemide (50 mg/kg) was administered intravenously within 15 min (group II); group I received an equal volume of half-normal saline. ARA was induced 1 h later (0 h) and arterial CO2 tension was maintained between 55 and 60 Torr for 5 h. Mean cisternal CSF PCO2 was 42.8 +/- 2.6 and 39.5 +/- 1.7 Torr, respectively in groups I and II and rose approximately 20 Torr during ARA. In group I, CSF [HCO3-] was 22.0 +/- 1.0, 24.8 +/- 0.6, and 25.4 +/- 1.6 meq/l, respectively at 0, 2.5, and 5 h. Respective values for group II were 22.2 +/- 1.3, 24.3 +/- 1.8, and 24.6 +/- 1.0 meq/l. These values were not significantly different from each other. In each group, CSF [Na+-Cl-] increased significantly during ARA, but the changes were not significantly different when the two groups were compared. We conclude that furosemide at the dose used in the present study does not change ionic composition and acid-base balance of cisternal CSF compared with control. Because changes in CSF [Na+-Cl-] during ARA were similar in both groups, any inhibition of Cl- influx into CSF by furosemide should have been proportional to that of Na+.
Javaheri
S
S
Pulmonary Section, Veterans Administration Medical Center, Cincinnati, Ohio.
Freidel
J F
JF
Davis
P J
PJ
D000136:Acid-Base Equilibrium; D000142:Acidosis, Respiratory / Q000134:cerebrospinal fluid*; D000818:Animals; D001639:Bicarbonates / Q000032:analysis; D001774:Blood Chemical Analysis; D001794:Blood Pressure; D002712:Chlorides / Q000032:analysis; D004285:Dogs; D004573:Electrolytes / Q000378:metabolism*; D005665:Furosemide / Q000494:pharmacology*; D006400:Hematocrit; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000097:blood; D011188:Potassium / Q000032:analysis; D012964:Sodium / Q000032:analysis; D013997:Time Factors
D001639:Bicarbonates; D002712:Chlorides; D004573:Electrolytes; D007773:Lactates; D005665:Furosemide; D012964:Sodium; D011188:Potassium